BioSpace News Archive

Business

MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results

“Monjuvi sales continued to build momentum in the third quarter where we saw a broadening of the prescriber base and increased utilization in second-line patients,” said Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys.

November 11, 2021
·
13 min read
Drug and Gene Delivery Systems Market Size to Accelerate at a Rapid CAGR of 6% from 2017 to 2025

The global market for drug and gene delivery systems features a largely consolidated vendor landscape with only a handful companies accounting for a dominant share in the overall market, observes Transparency Market Research in a recent report.

November 11, 2021
·
4 min read
Fluoroscopy Equipment Market to Register 6% CAGR as Demand for Multipurpose Imaging Tools Grows for Real-time Diagnosis

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global fluoroscopy equipment market size is estimated to exceed US$ 1.9 Bn in 2021.

November 11, 2021
·
8 min read
Antibody Fragments Market Trend Shows a Rapid Growth by 2024 According to New Research Report

Whole antibodies have grabbed a significant share of the global sales revenue as well as the volume of the biopharmaceuticals market.

November 11, 2021
·
6 min read
Teleradiology Services Market is Expected to Elevate to a Value of US$ 19.7 Bn by the End of 2031

According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. It is projected to expand at a CAGR of ~11% from 2021 to 2031.

November 11, 2021
·
5 min read
Relief Provides Corporate Update and Outlines Plans to Advance its Diversified Portfolio of Pipeline Candidates, Including RLF-100(TM) (Aviptadil)

RELIEF THERAPEUTICS Holding SA provided a corporate update detailing, among other matters, its ongoing clinical development and regulatory activities, as well as its plans to accelerate the maturation of its pipeline.

November 11, 2021
·
9 min read
Business

Ultimovacs ASA: Third quarter 2021 result presentation

Oslo, 11November 2021: Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announces its third quarter 2021 results.

November 11, 2021
·
3 min read
Drug Development

Allarity Therapeutics’ Oral PARP Inhibitor, Stenoparib, Demonstrates Pre-clinical Antiviral Activity Against Delta Variant of Coronavirus

Hørsholm, Denmark – Allarity Therapeutics A/S announced positive results from the further pre-clinical testing of the antiviral activity of its oral PARP inhibitor, stenoparib, against Coronavirus variant B.1.617.2.

November 11, 2021
·
7 min read
Deals

CrestOptics Acquired by Apposite Capital LLP to Enable Rapid Commercial Growth and Innovation in Bioimaging

CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, announced it has been acquired through a majority shareholding by Apposite Capital LLP, the healthcare specialist private equity investor.

November 11, 2021
·
3 min read
Genetown

Oncoheroes Biosciences Inc. Out-licences volasertib to Notable Labs for the Global Adult Development of Its Anticancer Therapy

Oncoheroes Biosciences Inc., a biotech focused on advancing new therapies for childhood cancer, has out-licensed worldwide the adult rights to Notable Labs, Inc., a clinical-stage predictive precision medicine company.

November 11, 2021
·
3 min read